Scriabin Program Research Map
AstraZeneca R&D Boston — Research Areas Overview
The Scriabin Research Program at AstraZeneca R&D Boston encompasses multiple interconnected research disciplines, all focused on advancing our understanding of gastrointestinal disease and developing improved therapeutic strategies. This research map provides an overview of the program’s key areas and navigational links to detailed resources within each focus area.
Scriabin Program Structure
H. Pylori Research
Helicobacter pylori infection mechanisms, virulence factors, eradication therapy optimization, and antibiotic resistance.
Acid Suppression Pharmacology
Proton pump inhibitor pharmacokinetics, CYP2C19 polymorphisms, intragastric pH optimization, and next-generation acid blockers.
Gastric Mucosal Biology
Gastric epithelial cell biology, mucosal defense mechanisms, inflammatory pathways, and cancer progression cascades.
Translational Medicine
Bridging laboratory discoveries with clinical applications, biomarker development, and patient stratification for H. pylori eradication.